Precision BioSciences Nets $7.5M from TG Therapeutics for Azer-cel MS Milestone

Precision BioSciences Achieves Clinical Milestone in Collaboration with TG Therapeutics, Securing $7.5 Million in Proceeds from Azer-Cel Program for Multiple Sclerosis Precision BioSciences, Inc, a leading clinical-stage biotechnology company specializing in gene editing technologies, announced today a significant milestone achievement…

Read More Precision BioSciences Nets $7.5M from TG Therapeutics for Azer-cel MS Milestone

Rallybio and Candid Therapeutics Announce Merger Deal

Rallybio and Candid Therapeutics Announce Transformative Merger and Oversubscribed Financing to Advance TCE Therapeutics for Autoimmune Diseases Rallybio Corporatin, and Candid Therapeutics, Inc. (“Candid”), a globally recognized clinical-stage biotechnology company specializing in T-cell engager (TCE) therapeutics for autoimmune diseases, have…

Read More Rallybio and Candid Therapeutics Announce Merger Deal

Thermo Fisher Unveils Rapid Color-Based Test for Candida, Including Resistant C. auris

Thermo Fisher Scientific Launches Advanced Chromogenic Culture Media for Rapid Candida Detection, Including Drug-Resistant Candida auris Thermo Fisher Scientific, a global leader in serving science, has announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar,…

Read More Thermo Fisher Unveils Rapid Color-Based Test for Candida, Including Resistant C. auris
Kayne

Kayne Anderson BDC Reports Year-End 2025 Results, Declares $0.40 First Quarter 2026 Dividend

Kayne Anderson BDC, Inc. Announces December 31, 2025 Financial Results and Declares First Quarter 2026 Dividend of $0.40 Per Share Kayne Anderson BDC, Inc. a business development company externally managed by its investment adviser, KA Credit Advisors, LLC, today announced…

Read More Kayne Anderson BDC Reports Year-End 2025 Results, Declares $0.40 First Quarter 2026 Dividend

Feinstein Institutes for Medical Research Finds Early Brain Warning Signs in Severe Liver Damage

Researchers at the Feinstein Institutes identify noninvasive biomarkers that detect early brain changes in acute liver injury, enabling faster intervention and improved patient outcomes. Scientists at the Feinstein Institutes for Medical Research, the research arm of Northwell Health, have unveiled…

Read More Feinstein Institutes for Medical Research Finds Early Brain Warning Signs in Severe Liver Damage